Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer
暂无分享,去创建一个
G. Iyer | C. Aghajanian | B. Manning-Geist | G. Gardner | Y. Sonoda | R. Grisham | S. Gordhandas | M. Chui | K. Moore | C. Henson